Kerafilm

Lactic acid and salicylic acid, the active ingredients in Kerafilm, are keratolytic agents presented as a topical formulation for skin application. They help to exfoliate the stratum corneum and reduce hyperkeratinisation in various dermatologic conditions.

GNH USA supplies Kerafilm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kerafilm, a topical keratolytic preparation, is used for disorders involving abnormal keratin buildup.

- Acne vulgaris: helps to unclog pores and reduce inflammatory lesions. - Keratosis pilaris: smooths rough, bumpy skin on arms and thighs. - Hyperkeratotic plaques: softens thickened skin in conditions such as seborrheic dermatitis or ichthyosis.

Kerafilm may cause local skin reactions, most of which are mild and reversible.

Common Side Effects: - Skin irritation: mild burning or stinging at the application site. - Redness: transient erythema following use. - Dryness: increased transepidermal water loss. - Peeling: superficial desquamation of the treated area. - Itching: occasional pruritus during the exfoliation process. - Sensitivity to sunlight: heightened photosensitivity.

Serious or Rare Side Effects: - Allergic contact dermatitis: severe rash, swelling, or blistering. - Bullous eruption: formation of large fluid‑filled blisters. - Hyperpigmentation: persistent darkening of the skin. - Contact urticaria: hives localized to the area of application. - Severe chemical burn: intense pain and tissue damage. - Systemic absorption reactions: rare systemic effects in extensive use.

When using Kerafilm, consider the following safety measures.

- Avoid on compromised skin: do not apply to open wounds, abrasions, or inflamed lesions. - Patch test: perform a 24‑hour test on a small area before full application. - Sun exposure: limit UV exposure and use sunscreen after treatment. - Pregnancy and lactation: consult a healthcare professional before use. - Eye contact: keep away from eyes; rinse thoroughly if accidental contact occurs. - Concurrent topical acids: do not combine with other keratolytic or retinoid products without medical advice. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Kerafilm may interact with other topical or systemic agents.

Major Interactions (Avoid): - Other keratolytic agents: concurrent use with high‑strength acids or retinoids can increase irritation. - Photosensitizing drugs: avoid combining with systemic photosensitizers (e.g., tetracyclines) due to heightened sun sensitivity. - Antifungal creams containing azoles: may alter skin barrier and increase absorption.

Moderate Interactions (Monitor Closely): - Systemic salicylates: monitor for additive salicylate exposure, especially in patients on high oral doses. - Anticoagulants: observe for increased bleeding risk if large skin areas are treated. - Topical steroids: may reduce efficacy of Kerafilm if used simultaneously. - Cosmetic products with alcohol: can exacerbate dryness and irritation. - Moisturizers with occlusive agents: may affect drug penetration and increase local side effects.